DouglasLehrerMD

PubMed

• 24 citations
  Prognostic value of polygenic risk scores for adults with psychosis
  Isotta Landi, Deepak Kaji, Liam Cotter, Tielman Van Vleck, Gillian M. Belbin, Michael Preuss, Ruth J. F. Loos, Eimear E. Kenny, Benjamin S. Glicksberg, Noam D. Beckman...> ;Nature Medicine. 2021 Sep 1
• 6 citations
  Oral and Topical Vitamin D, Sunshine, and UVB Phototherapy Safely Control Psoriasis in Patients with Normal Pretreatment Serum 25-Hydroxyvitamin D Concentrations: A Li...
  Patrick J. McCullough, William P. McCullough, Douglas S. Lehrer, Jeffrey B. Travers, Steven J. Repas> ;Nutrients. 2021 Apr 29
• 8 citations
  Dopamine receptor density and white mater integrity: 18 F-fallypride positron emission tomography and diffusion tensor imaging study in healthy and schizophrenia subjects
  Serge A. Mitelman, Monte S. Buchsbaum, Bradley T. Christian, Brian Merrill, Bradley R. Buchsbaum, Jogeshwar Mukherjee, Douglas S. Lehrer> ;Brain Imaging and Behavior. 2020 Jun 1
• 36 citations
  Contribution of Rare Copy Number Variants to Bipolar Disorder Risk Is Limited to Schizoaffective Cases
  Alexander W. Charney, Eli A. Stahl, Elaine K. Green, Chia-Yen Chen, Jennifer L. Moran, Kimberly Chambert, Richard A. Belliveau, Liz Forty, Katherine Gordon-Smith, Phil...> ;Biological Psychiatry. 2019 Jul 15
• 48 citations
  Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: Insights from a seven year experience
  Patrick J. McCullough, Douglas S. Lehrer, Jeffrey Amend> ;The Journal of Steroid Biochemistry and Molecular Biology. 2019 May 1
• 19 citations
  Comparing Global Assessment of Functioning (GAF) and World Health Organization Disability Assessment Schedule (WHODAS) 2.0 in schizophrenia.
  Scott Gspandl, Ryan P. Peirson, Ramzi W. Nahhas, Tracey Goodman Skale, Douglas S. Lehrer> ;Psychiatry Research. 2018 Jan 1
• 19 citations
  Vitamin D, cod liver oil, sunshine, and phototherapy: Safe, effective and forgotten tools for treating and curing tuberculosis infections - A comprehensive review.
  Patrick J. McCullough, Douglas S. Lehrer> ;The Journal of Steroid Biochemistry and Molecular Biology. 2017 Jul 26
• 12 citations
  D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophrenia.
  Nora S. Vyas, Monte S. Buchsbaum, Douglas S. Lehrer, Brian Merrill, Alex DeCastro, Nicholas A. Doninger, Bradley T. Christian, Jogeshwar Mukherjee> ;Schizophrenia Research. 2018 Feb 1
• 24 citations
  Anosognosia in schizophrenia: Hidden in plain sight.
  Douglas S. Lehrer, Jennifer Lorenz> ;Innovations in Clinical Neuroscience. 2014 May 1
• 25 citations
  18F-Fallypride binding potential in patients with schizophrenia compared to healthy controls
  Douglas S. Lehrer, Bradley T. Christian, Cemil Kirbas, Meicheng Chiang, Shawn Sidhu, Holly Short, Binquan Wang, Bingzhi Shi, King-Wai Chu, Brian Merrill, Monte S. Buch...> ;Schizophrenia Research. 2010 Sep 1
• 99 citations
  D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia
  Monte S. Buchsbaum, Bradley T. Christian, Douglas S. Lehrer, Tanjore K. Narayanan, Bingzhi Shi, Joseph Mantil, Eileen Kemether, Terrence R. Oakes, Jogeshwar Mukherjee> ;Schizophrenia Research. 2006 Jul 1
• 63 citations
  Measuring dopamine neuromodulation in the thalamus: Using [F-18]fallypride PET to study dopamine release during a spatial attention task
  Bradley T. Christian, Douglas S. Lehrer, Bingzhi Shi, Tanjore K. Narayanan, Pamela Strohmeyer, Monte S. Buchsbaum, Joseph Mantil> ;Neuroimage. 2006 May 15
• 47 citations
  Thalamic and prefrontal FDG uptake in never medicated patients with schizophrenia.
  Douglas S. Lehrer, Bradley T. Christian, Joseph Mantil, Aaron C. Murray, Bradley R. Buchsbaum, Terrence R. Oakes, William Byne, Eileen Kemether, Monte S. Buchsbaum> ;The American Journal of Psychiatry. 2005 May 1
• Join now to see all